AnsellASX:ANN +1.06%74 FCF Yield % is 7.05 as of Jun. 26, 2026, which is 19% above its 10-year median of 5.91. GuruFocus rates ASX:ANN with a GF Score™ of 74/100 and a GF Value™ of A$29.15 (Fairly Valued). The stock has 4 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Ansell ranks better than 89.01% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Ansell's Trailing 12-Month Free Cash Flow is A$316 Mil, and Market Cap is A$4,479 Mil. Therefore, Ansell's FCF Yield % for today is 7.05%.
The historical rank and industry rank for Ansell's FCF Yield % or its related term are showing as below:
ASX:ANN'
s FCF Yield % Range Over the Past 10 Years
Min: 2.18 Med: 5.91 Max: 9.51
Current: 7.05
During the past 13 years, the highest FCF Yield % of Ansell was 9.51%. The lowest was 2.18%. And the median was 5.91%.
ASX:ANN's FCF Yield % is ranked better than 89.01% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: -0.38
vs ASX:ANN: 7.05
Ansell's FCF Margin % for the quarter that ended in Dec. 2025 was 12.16%.
Ansell FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Ansell FCF Yield % Related Terms
Ansell FCF Yield % Historical Data
* Premium members only.
The historical data trend for Ansell's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:ANN vs ISRG, BDX, MDLN: FCF Yield % Comparison
For the Medical Instruments & Supplies subindustry, Ansell's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ansell FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ansell's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Ansell's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ansell (ASX:ANN) has a FCF Yield % of 7.05 as of Jun. 26, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Ansell and its competitors. This is 19% above median its historical median of 5.91. Over the past decade, Ansell's FCF Yield % has ranged from 2.18 to 9.51. According to the industry distribution chart, Ansell ranks #94 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 11%.
Is Ansell's FCF Yield % too high?
Ansell's current FCF Yield % of 7.05 is 19% above median its 10-year median of 5.91. Over the past 10 years, this metric has ranged from a low of 2.18 to a high of 9.51. Based on the distribution chart, Ansell ranks #94 out of 855 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Ansell has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ansell's FCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ansell ranks #94 out of 855 companies for FCF Yield %. This places Ansell in the top 11% of its industry — outperforming the majority of peers. Historically, Ansell's own FCF Yield % has ranged from 2.18 to 9.51 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Ansell and its competitors. Ansell's current FCF Yield % is 7.05, which is 19% above median its own 10-year median of 5.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ansell stock overvalued right now?
Based on GuruFocus' analysis, Ansell (ASX:ANN) is currently considered Fairly Valued. The stock's GF Value™ is A$29.15, compared to a current price of A$31.47 — trading 8% above its estimated fair value. The current FCF Yield % is 7.05, which is 19% above median its 10-year median of 5.91. Ansell's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Ansell (ASX:ANN), the current FCF Yield % is 7.05 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ansell (ASX:ANN) Overvalued in 2026?
Based on GuruFocus' analysis, Ansell stock appears to be overvalued.
The current stock price of A$31.47 is trading 8% above its estimated GF Value™ of A$29.15.
GuruFocus considers Ansell to be Fairly Valued.
Key valuation signals for ASX:ANN:
FCF Yield %: 7.05 (19% above median its 10-year median of 5.91)
GF Value™: A$29.15 vs. price of A$31.47 (8% above fair value)
No single metric tells the full story. See the ASX:ANN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 55% of revenue and operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents, and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly. Largest sales regions are North America and Europe, Middle East, and Africa. Asia-Pacific and Latin America, combined, are about one-fourth of sales.
74GF Score
Get the complete analysis for ASX:ANN
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ANN has been successfully added to your 
